Avoiding drug-drug interactions

Chemotherapy

Volumn 55, Issue 4, 2009, Pages 215-220

  Åstrand, Bengt ^a,b  

^a LINNAEUS UNIVERSITY   (Sweden)

^b Apoteket AB   (Sweden)

Author keywords

Drug interactions; Pharmacoinformatics; Polypharmacy; Prescriptions, drug

Indexed keywords

ANTIINFECTIVE AGENT; ANTIRETROVIRUS AGENT; VERAPAMIL; VINCRISTINE;

ADVERSE DRUG REACTION; AUSTRALIA; DENMARK; DRUG ANTAGONISM; DRUG INTERACTION; DRUG POTENTIATION; DRUG SURVEILLANCE PROGRAM; ELECTRONIC MEDICAL RECORD; HOSPITAL ADMISSION; HUMAN; INCIDENCE; KNOWLEDGE BASE; MEDLINE; MORTALITY; NETHERLANDS; NONHUMAN; PHARMACOGENETICS; POLYPHARMACY; PRESCRIPTION; PRIORITY JOURNAL; REGISTER; REVIEW; SWEDEN; UNITED STATES;

DRUG INTERACTIONS; DRUG MONITORING; DRUG THERAPY; DRUG THERAPY, COMBINATION; DRUG TOXICITY; HISTORY OF MEDICINE; HISTORY, 18TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, ANCIENT; HUMANS; PHARMACOEPIDEMIOLOGY; POLYPHARMACY;

EID: 65549122202     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000218100     Document Type: Review

References (59)

1. Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP: Adverse drug events in hospitalized patients: excess length of stay, extra costs, and attributable mortality. JAMA 1997;277:301-306.
2. Levy M, Kewitz H, Altwein W, Hillebrand J, Eliakim M: Hospital admissions due to adverse drug reactions: a comparative study from Jerusalem and Berlin. Eur J Clin Pharmacol 1980;17:25-31.
3. van der Hooft CS, Sturkenboom MC, van Grootheest K, Kingma HJ, Stricker BH: Adverse drug reaction-related hospitalisations: a nationwide study in The Netherlands. Drug Saf 2006;29:161-168.
4. Schneeweiss S, Hasford J, Gottler M, Hoffmann A, Riethling AK, Avorn J: Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study. Eur J Clin Pharmacol 2002;58:285-291.
5. Lazarou J, Pomeranz BH, Corey PN: Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998;279:1200-1205.
6. Fuhr U: Improvement in the handling of drug-drug interactions. Eur J Clin Pharmacol 2008;64:167-171.
7. Heberden W: Antitherica - an essay on Mithridatium and Theriaca. R Coll Phys Tracts 1745;112.
8. Griffin JP: Venetian treacle and the foundation of medicines regulation. Br J Clin Pharmacol 2004;58:317-325.
9. Mann RD: From mithridatium to modern medicine: the management of drug safety. J R Soc Med 1988;81:725-728.
10. Sorgel F: The return of Ehrlich's 'Therapia magna sterilisans' and other Ehrlich concepts? Series of papers honoring Paul Ehrlich on the occasion of his 150th birthday. Chemotherapy 2004;50:6-10.
11. Nilsson JL, Melander A: Increased introduction, advertising, and sales of preventive drugs during 1986-2002 in Sweden. J Ambul Care Manage 2006;29:238-249.
12. Alvan G, Bertilsson L, Dahl ML, IngelmanSundberg M, Sjöqvist F: Moving toward genetic profiling in patient care: the scope and rationale of pharmacogenetic/ecogenetic investigation. Drug Metab Dispos 2001;29:580-585.
13. Aronson JK: In defence of polypharmacy. Br J Clin Pharmacol 2004;57:119-120.
14. Aronson JK: Rational prescribing, appropriate prescribing. Br J Clin Pharmacol 2004;57:229-230.
15. Ferrendelli JA: Rational polypharmacy. Epilepsia 1995;36 (suppl 2):S115-S118.
16. Hogerzeil HV: Promoting rational prescribing: an international perspective. Br J Clin Pharmacol 1995;39:1-6.
17. Pollock M, Bazaldua OV, Dobbie AE: Appropriate prescribing of medications: an eight-step approach. Am Fam Physician 2007;75:231-236.
18. Tamblyn RM, McLeod PJ, Abrahamowicz M, Laprise R: Do too many cooks spoil the broth? Multiple physician involvement in medical management of elderly patients and potentially inappropriate drug combinations. CMAJ 1996;154:1177-1184.
19. Hansagi H, Olsson M, Sjöberg S, Tomson Y, Goransson S: Frequent use of the hospital emergency department is indicative of high use of other health care services. Ann Emerg Med 2001;37:561-567.
20. Björkman IK, Fastbom J, Schmidt IK, Bernsten CB: Drug-drug interactions in the elderly. Ann Pharmacother 2002;36:1675-1681.
21. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA: Recent patterns of medication use in the ambulatory adult population of the United States: the Slone Survey. JAMA 2002;287:337-344.
22. Merlo J, Liedholm H, Lindblad U, BjörckLinné A, Fält J, Lindberg G, Melander A: Prescriptions with potential drug interactions dispensed at Swedish pharmacies in January 1999: cross sectional study. BMJ 2001;323:427-428.
23. Rosholm JU, Bjerrum L, Hallas J, Worm J, Gram LF: Polypharmacy and the risk of drug-drug interactions among Danish elderly: a prescription database study. Dan Med Bull 1998;45:210-213.
24. Bergendal L, Friberg A, Schaffrath A: Potential drug-drug interactions in 5,125 mostly elderly out-patients in Gothenburg, Sweden. Pharm World Sci 1995;17:152-157.
25. Bjerrum L, Andersen M, Petersen G, Kragstrup J: Exposure to potential drug interactions in primary health care. Scand J Prim Health Care 2003;21:153-158.
26. Fulton MM, Allen ER: Polypharmacy in the elderly: a literature review. J Am Acad Nurse Pract 2005;17:123-132.
27. Jörgensen T, Johansson S, Kennerfalk A, Wallander MA, Svärdsudd K: Prescription drug use, diagnoses, and healthcare utilization among the elderly. Ann Pharmacother 2001;35:1004-1009.
28. Lafata JE, Schultz L, Simpkins J, Chan KA, Horn JR, Kaatz S, Long C, Platt R, Raebel MA, Smith DH, Xi H, Yood MU: Potential drug-drug interactions in the outpatient setting. Med Care 2006;44:534-541.
29. Gross ME: A self-medication administration program. J Geriatr Drug Ther 1992;6:879889.
30. Leape LL, Bates DW, Cullen DJ, Cooper J, Demonaco HJ, Gallivan T, Hallisey R, Ives J, Laird N, Laffel G, et al: Systems analysis of adverse drug events. ADE Prevention Study Group. JAMA 1995;274:35-43.
31. Mjörndal T, Boman MD, Hägg S, Bäckstrom M, Wiholm BE, Wahlin A, Dahlqvist R: Adverse drug reactions as a cause for admissions to a department of internal medicine. Pharmacoepidemiol Drug Saf 2002;11:65-72.
32. Huang SM, Lesko LJ: Drug-drug, drug-dietary supplement, and drug-citrus fruit and other food interactions: what have we learned? J Clin Pharmacol 2004;44:559-569.
33. Pontali E: Interactions of antiretroviral drugs with anti-infectives and other antiretrovirals. Chemotherapy 2007;53:26-29.
34. Balayssac D, Cayre A, Ling B, Maublant J, Penault-Llorca F, Eschalier A, Coudore F, Authier N: Vincristine-induced neuropathy in the rat is not modified by drug-drug interactions with the P-glycoprotein inhibitor verapamil. Chemotherapy 2008;54:336-4233.
35. Astrand B: e-Prescribing - Studies in Pharmacoinformatics. Kalmar, School of Pure and Natural Sciences, University of Kalmar, 2007.
36. Astrand E, Åstrand B, Antonov K, Petersson G: Potential drug interactions during a three-decade study period: a cross-sectional study of a prescription register. Eur J Clin Pharmacol 2007;63:851-859.
37. Johnell K, Klarin I: The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish Prescribed Drug Register. Drug Saf 2007;30:911-918.
38. Astrand B, Åstrand E, Antonov K, Petersson G: Detection of potential drug interactions - a model for a national pharmacy register. Eur J Clin Pharmacol 2006;62:749-756.
39. Gardner D: Using genomics to help predict drug interactions. J Biomed Inform 2004;37:139-146.
40. Coiera E, Westbrook J, Wyatt J: The safety and quality of decision support systems. Methods Inf Med 2006;45(suppl 1):20-25.
41. Weingart SN, Toth M, Sands DZ, Aronson MD, Davis RB, Phillips RS: Physicians' decisions to override computerized drug alerts in primary care. Arch Intern Med 2003;163:2625-2631.
42. Lapane KL, Waring ME, Schneider KL, Dube C, Quilliam BJ: A mixed method study of the merits of e-prescribing drug alerts in primary care. J Gen Intern Med 2008;23:442-446.
43. Shah NR, Seger AC, Seger DL, Fiskio JM, Kuperman GJ, Blumenfeld B, Recklet EG, Bates DW, Gandhi TK: Improving override rates for computerized prescribing alerts in ambulatory care. AMIA Annu Symp Proc 2005, p 1110.
44. Gunter TD, Terry NP: The emergence of national electronic health record architectures in the United States and Australia: models, costs, and questions. J Med Internet Res 2005;7:e3.
45. Watson N: Patients should have to opt out of national electronic care records: FOR. BMJ 2006;333:39-40.
46. Halamka JD: Patients should have to opt out of national electronic care records: AGAINST. BMJ 2006;333:41-42.
47. Sprague L: Personal health records: the people's choice? NHPF Issue Brief 2006;1-13.
48. Herborg H, Sørensen EW, Frøkjaer B: Pharmaceutical care in community pharmacies: practice and research in Denmark. Ann Pharmacother 2007;41:681-689.
49. Åstrand B, Hovstadius B, Antonov K, Petersson G: The Swedish National Pharmacy Register. Stud Health Technol Inform 2007;129:345-349.
50. Eriksson U, Nilsson AL: Utvidgad pilot Läkemedelsförteckningen Utvärderingsrapport. Stockholm, Swedish Association of Local Authorities and Regions and The National Corporation of Pharmacies, 2007.
51. Leonard KJ: The role of patients in designing health information systems: the case of applying simulation techniques to design an electronic patient record (EPR) interface. Health Care Manag Sci 2004;7:275-284.
52. Honeyman A, Cox B, Fisher B: Potential impacts of patient access to their electronic care records. Inform Prim Care 2005;13:55-60.
53. Ross SE, Todd J, Moore LA, Beaty BL, Wittevrongel L, Lin CT: Expectations of patients and physicians regarding patient-accessible medical records. J Med Internet Res 2005;7:e13.
54. Masys D, Baker D, Butros A, Cowles KE: Giving patients access to their medical records via the internet: the PCASSO experience. J Am Med Inform Assoc 2002;9:181-191.
55. Institute of Medicine. Letter report: Key capabilities of an electronic health record system. National Academies Press, Washington, 2003. http://www.providersedge.com/ehdocs/ehr-articles/Key-Capabilities-of-an-EHR- System.pdf Archived at: http://www.webcitation.org/5QcN8U6hd 2007-07-26.
56. Pyper C, Amery J, Watson M, Crook C: Patients' experiences when accessing their online electronic patient records in primary care. Br J Gen Pract 2004;54:38-43.
57. Åstrand E, Åstrand B, Hovstadius B, Petersson G: Individuals appreciate their medication record on the web: a survey of attitudes to a national pharmacy register. J Med Internet Res 2008;10:e35.
58. Hallas J: Conducting pharmacoepidemiologic research in Denmark. Pharmacoepidemiol Drug Saf 2001;10:619-623.
59. Wettermark B, Hammar N, Fored CM, Leimanis A, Otterblad Olausson P, Bergman U, Persson I, Sundström A, Westerholm B, Rosén M: The new Swedish Prescribed Drug Register-Opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf 2007;16:726-735